172 related articles for article (PubMed ID: 28623279)
1. Divergent Regulation of Actin Dynamics and Megakaryoblastic Leukemia-1 and -2 (Mkl1/2) by cAMP in Endothelial and Smooth Muscle Cells.
Smith MC; Hudson CA; Kimura TE; White SJ; Sala-Newby GB; Newby AC; Bond M
Sci Rep; 2017 Jun; 7(1):3681. PubMed ID: 28623279
[TBL] [Abstract][Full Text] [Related]
2. cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.
Duggirala A; Kimura TE; Sala-Newby GB; Johnson JL; Wu YJ; Newby AC; Bond M
J Mol Cell Cardiol; 2015 Feb; 79():157-68. PubMed ID: 25446180
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.
Kimura TE; Duggirala A; Hindmarch CC; Hewer RC; Cui MZ; Newby AC; Bond M
J Mol Cell Cardiol; 2014 Jul; 72(100):9-19. PubMed ID: 24534707
[TBL] [Abstract][Full Text] [Related]
4. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
Kimura TE; Duggirala A; Smith MC; White S; Sala-Newby GB; Newby AC; Bond M
J Mol Cell Cardiol; 2016 Jan; 90():1-10. PubMed ID: 26625714
[TBL] [Abstract][Full Text] [Related]
5. Decreased Jagged1 expression in vascular smooth muscle cells delays endothelial regeneration in arteriovenous graft.
Guo Q; Huang F; Qing Y; Feng S; Xiao X; Wang Y; Liang M; Wang T; Mitch WE; Cheng J
Cardiovasc Res; 2020 Nov; 116(13):2142-2155. PubMed ID: 31913453
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K.
Torella D; Gasparri C; Ellison GM; Curcio A; Leone A; Vicinanza C; Galuppo V; Mendicino I; Sacco W; Aquila I; Surace FC; Luposella M; Stillo G; Agosti V; Cosentino C; Avvedimento EV; Indolfi C
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2015-25. PubMed ID: 19783773
[TBL] [Abstract][Full Text] [Related]
7. Nuclear actin regulates cell proliferation and migration via inhibition of SRF and TEAD.
McNeill MC; Wray J; Sala-Newby GB; Hindmarch CCT; Smith SA; Ebrahimighaei R; Newby AC; Bond M
Biochim Biophys Acta Mol Cell Res; 2020 Jul; 1867(7):118691. PubMed ID: 32119877
[TBL] [Abstract][Full Text] [Related]
8. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
Cen B; Selvaraj A; Burgess RC; Hitzler JK; Ma Z; Morris SW; Prywes R
Mol Cell Biol; 2003 Sep; 23(18):6597-608. PubMed ID: 12944485
[TBL] [Abstract][Full Text] [Related]
9. Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration.
Kircher P; Hermanns C; Nossek M; Drexler MK; Grosse R; Fischer M; Sarikas A; Penkava J; Lewis T; Prywes R; Gudermann T; Muehlich S
Sci Signal; 2015 Nov; 8(402):ra112. PubMed ID: 26554816
[TBL] [Abstract][Full Text] [Related]
10. MYOSLID Is a Novel Serum Response Factor-Dependent Long Noncoding RNA That Amplifies the Vascular Smooth Muscle Differentiation Program.
Zhao J; Zhang W; Lin M; Wu W; Jiang P; Tou E; Xue M; Richards A; Jourd'heuil D; Asif A; Zheng D; Singer HA; Miano JM; Long X
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2088-99. PubMed ID: 27444199
[TBL] [Abstract][Full Text] [Related]
11. The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.
McKean JS; Murray F; Gibson G; Shewan DA; Tucker SJ; Nixon GF
Cardiovasc Res; 2015 Sep; 107(4):546-55. PubMed ID: 26092100
[TBL] [Abstract][Full Text] [Related]
12. Identification of the intermediate filament protein synemin/SYNM as a target of myocardin family coactivators.
Swärd K; Krawczyk KK; Morén B; Zhu B; Matic L; Holmberg J; Hedin U; Uvelius B; Stenkula K; Rippe C
Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1128-C1142. PubMed ID: 31461342
[TBL] [Abstract][Full Text] [Related]
13. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation.
Selvaraj A; Prywes R
J Biol Chem; 2003 Oct; 278(43):41977-87. PubMed ID: 14565952
[TBL] [Abstract][Full Text] [Related]
14. Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP.
Smith SA; Newby AC; Bond M
Cells; 2019 Nov; 8(11):. PubMed ID: 31744111
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase 14 is a novel negative regulatory switch for the vascular smooth muscle cell contractile gene program.
Long X; Cowan SL; Miano JM
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):378-86. PubMed ID: 23175675
[TBL] [Abstract][Full Text] [Related]
16. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.
Mottola G; Chatterjee A; Wu B; Chen M; Conte MS
PLoS One; 2017; 12(3):e0174936. PubMed ID: 28362840
[TBL] [Abstract][Full Text] [Related]
17. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
Cen B; Selvaraj A; Prywes R
J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
[TBL] [Abstract][Full Text] [Related]
18. NG2/CSPG4, CD146/MCAM and VAP1/AOC3 are regulated by myocardin-related transcription factors in smooth muscle cells.
Rippe C; Morén B; Liu L; Stenkula KG; Mustaniemi J; Wennström M; Swärd K
Sci Rep; 2021 Mar; 11(1):5955. PubMed ID: 33727640
[TBL] [Abstract][Full Text] [Related]
19. ARF GTPases control phenotypic switching of vascular smooth muscle cells through the regulation of actin function and actin dependent gene expression.
Charles R; Bourmoum M; Claing A
Cell Signal; 2018 Jun; 46():64-75. PubMed ID: 29499306
[TBL] [Abstract][Full Text] [Related]
20. G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell Proliferation.
McCallum JE; Mackenzie AE; Divorty N; Clarke C; Delles C; Milligan G; Nicklin SA
J Vasc Res; 2015; 52(6):383-95. PubMed ID: 27064272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
